Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

DOI Full Paper Access

40

Citations

33

References

2024

Year

Cynthia Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C Cagnoli, W. Winn Chatham, Kenneth L. Clark, Richard Furie, James Groark, Murray B. Urowitz,

Annals of the Rheumatic Diseases

Abstract

NCT03312907.

References

	Year	Citations

Page 1